April 30, 2021
April 30, 2021 – The U.S. FDA has approved KloxxadoTM (naloxone hydrochloride) nasal spray,
manufactured by Hikma Pharmaceuticals, for the emergency treatment of known
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
Global Reach Health News
April 30, 2021
April 30, 2021 – Acella Pharmaceuticals has voluntarily recalled more than 30 lots of 15mg, 30mg, 60mg,
90mg, and 120mg NP Thyroid®, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine
April 30, 2021
April 30, 2021 – The U.S. FDA has approved a new indication for Farxiga® (dapagliflozin), manufactured by
AstraZeneca. The drug is now indicated for use in adults who have chronic kidney disease
April 28, 2021
April 28, 2021 – The U.S. FDA has approved a new indication for NatrobaTM (spinosad) topical solution
0.9%, manufactured by ParaPRO, to treat scabies infestations in patients who are at
April 26, 2021
April 26, 2021 – The U.S. FDA and Centers for Disease Control and Prevention (CDC) have lifted their
recommendation to pause distribution of Johnson & Johnson’s (J&J) COVID-19 vaccine
April 23, 2021
April 23, 2021 – The U.S. FDA has approved ZynlontaTM (loncastuximab tesirine-lpyl), manufactured by ADC
Therapeutics, to treat adults who have relapsed or refractory large B-cell lymphoma
April 22, 2021
April 22, 2021 – The U.S. FDA has granted accelerated approval to Jemperli® (dostarlimab-gxly),
manufactured by GlaxoSmithKline, to treat mismatch repair deficient (dMMR)
April 21, 2021
April 21, 2021 – The U.S. FDA has approved an expanded indication for Evekeo® ODT (amphetamine
sulfate) orally disintegrating tablets, manufactured by Arbor Pharmaceuticals.